SCHEMBL31437155

SCHEMBL31437155

CC(=O)NCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.44
▸ CTSL P07711 3/20 0.44
▸ CTSS P25774 3/20 0.44
▸ CTSK P43235 3/20 0.44
▸ CTSH P09668 1/20 0.44
▸ C5AR1 P21730 1/20 0.43
▸ APLNR P35414 2/20 0.40
▸ NPY4R P50391 7/20 0.39
▸ NPY1R P25929 4/20 0.39
▸ NPY2R P49146 4/20 0.39
▸ NPY5R Q15761 4/20 0.39
▸ MC4R P32245 1/20 0.39
▸ PRKACB P22694 1/20 0.38
▸ TUBB4A P04350 2/20 0.38
▸ TUBB P07437 2/20 0.38
▸ TUBA3C P0DPH7 2/20 0.38
▸ TUBA1B P68363 2/20 0.38
▸ TUBA4A P68366 2/20 0.38
▸ TUBB4B P68371 2/20 0.38
▸ TUBB3 Q13509 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29614491 0.96 CTSL (0.46) SLC15A2CTSLCTSSCTSKCTSH
SCHEMBL29614488 0.96 CTSL (0.46) SLC15A2CTSLCTSSCTSKCTSH
SCHEMBL31437150 0.94 CTSL (0.47) CTSLCTSSCTSKCTSHNPY4R
SCHEMBL29562123 0.93 SLC15A2 (0.43) SLC15A2C5AR1APLNRNPY4RNPY1R
SCHEMBL31315020 0.93 SLC15A2 (0.43) SLC15A2C5AR1APLNRNPY4RNPY1R
SCHEMBL29614462 0.92 TFPI (0.46) CTSLCTSSCTSKCTSHC5AR1
SCHEMBL31064774 0.91 SLC15A2 (0.54) SLC15A2C5AR1APLNRNPY4RNPY1R
SCHEMBL30818464 0.91 SLC15A2 (0.54) SLC15A2C5AR1APLNRNPY4RNPY1R
SCHEMBL29384678 0.90 NPY4R (0.46) SLC15A2C5AR1NPY4RNPY1RNPY2R
SCHEMBL31474897 0.89 APLNR (0.50) C5AR1APLNRNPY4RNPY1RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025037993-A1 DOSAGE FORM FOR PEPTIDE AGENTS MAJEWSKI FILIP (PL) 2025-02-20 — — WO claimed
WO-2025037993-A1 DOSAGE FORM FOR PEPTIDE AGENTS MAJEWSKI FILIP (PL) 2025-02-20 — — WO disclosed
WO-2025037992-A1 NEW PEPTIDES AND USE THEREOF MAJEWSKI FILIP (PL) 2025-02-20 — — WO disclosed
Send feedback